Abbott India is currently trading at Rs. 15400.00, up by 502.55 points or 3.37% from its previous closing of Rs. 14897.45 on the BSE.
The scrip opened at Rs. 14801.10 and has touched a high and low of Rs. 15700.00 and Rs. 14801.10 respectively. So far 1850 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 18569.00 on 04-May-2020 and a 52 week low of Rs. 8,317.50 on 1-Aug-2019.
Last one week high and low of the scrip stood at Rs. 15700.00 and Rs. 14749.80 respectively. The current market cap of the company is Rs. 32589.20 crore.
The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 7.32% and 17.69% respectively.
Abbott and leading online pharmacy and healthcare platform, 1mg have entered into collaboration to make Abbott’s continuous glucose monitoring products available online, including its professional flash glucose monitoring system, FreeStyle Libre Pro. Patients in India can upload a healthcare practitioner’s prescription and purchase the product online on 1mg. An on-site phlebotomy service will be provided at the patient’s home with a phlebotomist helping the patient administer the sensor and take readings of the data after 14 days, enabling them to start using the device.
Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: